Operating Margin of Taysha Gene Therapies, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Taysha Gene Therapies, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Taysha Gene Therapies, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -1619%, a 83% decline year-over-year.
  • Taysha Gene Therapies, Inc. annual Operating Margin for 2024 was -1098%, a 134% decline from 2023.
  • Taysha Gene Therapies, Inc. annual Operating Margin for 2023 was -469%, a 93% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Taysha Gene Therapies, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1619% -733% -83% 01 Jul 2025 30 Sep 2025
Q2 2025 -1161% -554% -91% 01 Apr 2025 30 Jun 2025
Q1 2025 -1226% -659% -116% 01 Jan 2025 31 Mar 2025
Q4 2024 -1098% -629% -134% 01 Oct 2024 31 Dec 2024
Q3 2024 -885% 01 Jul 2024 30 Sep 2024
Q2 2024 -607% 01 Apr 2024 30 Jun 2024
Q1 2024 -567% 01 Jan 2024 31 Mar 2024
Q4 2023 -469% 01 Oct 2023 31 Dec 2023

Taysha Gene Therapies, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -1098% -629% -134% 01 Jan 2024 31 Dec 2024
2023 -469% +6024% +93% 01 Jan 2023 31 Dec 2023
2022 -6493% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.